StemGen, Inc.
SGNI · OTC
6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | |
|---|---|---|---|---|
| Market Cap | $45,600 | $36,343 | $25,669 | $15,492 |
| - Cash | $1 | $0 | $3 | $0 |
| + Debt | $563 | $563 | $563 | $560 |
| Enterprise Value | $46,162 | $36,906 | $26,230 | $16,052 |
| Revenue | $39 | $19 | $22 | $0 |
| % Growth | 101.6% | -12.3% | – | – |
| Gross Profit | $9 | $11 | $14 | $0 |
| % Margin | 21.9% | 55.7% | 61.4% | – |
| EBITDA | -$180 | -$71 | -$308 | $98 |
| % Margin | -461.2% | -364.9% | -1,396.3% | – |
| Net Income | -$433 | -$231 | -$426 | $6 |
| % Margin | -1,110.3% | -1,192.6% | -1,931.3% | – |
| EPS Diluted | -0.01 | -0.008 | -0.02 | 0 |
| % Growth | -15.9% | 59% | -5,100% | – |
| Operating Cash Flow | -$141 | -$37 | -$105 | -$8 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$141 | -$37 | -$105 | -$8 |